results, potential and shareprice, page-14

Hi Lozza,

Up 15 in adverse markets, now $2.65.

Now with 2 trials on the way and hopefully the Cervical cancer trial to be announced before too long we have something to look forward to for a start.

It is possible that the US was buying, I don't know.

However, NRT has been too long in the accumulation stage anyway and a breakout had to come?

Perhaps some Sydney hospital nurses can tell you more?

Exciting times have arrived- our fall back position is NV07A of course.
I believe that slowly Analysts are preparing reports and there may be some sporadic news items.

Wait till it hits $3 and then we may get more cooperation from the News controllers.

Cheers,

Gerry